🇺🇸 FDA
Pipeline program

Ladarixin, Placebo to match Ladarixin

LDX0319

Phase 2 small_molecule active

Quick answer

Ladarixin, Placebo to match Ladarixin for Recent onset Type 1 Diabetes is a Phase 2 program (small_molecule) at Dompe' Farmaceutici S.p.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Dompe' Farmaceutici S.p.A.
Indication
Recent onset Type 1 Diabetes
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials